^
Association details:
Biomarker:No biomarker
Cancer:Small Lymphocytic Lymphoma
Drug:Zydelig (idelalisib) (PI3Kδ inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Chronic lymphocytic leukemia/Small lymphocytic lymphoma…Other recommended regimens…Idelalisib